Suppr超能文献

选择用于核心结局集的结局测量工具,以改善初级保健中老年人群中适当的多药治疗:一项德尔菲共识研究。

Selection of outcome measurement instruments for a core outcome set for trials aimed at improving appropriate polypharmacy in older people in primary care: a Delphi consensus study.

机构信息

Primary Care Research Group, School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast, BT9 7BL, UK.

出版信息

Int J Clin Pharm. 2024 Dec;46(6):1391-1399. doi: 10.1007/s11096-024-01780-4. Epub 2024 Jul 23.

Abstract

BACKGROUND

Despite developing a polypharmacy core outcome set (COS) in primary care, it is not clear how these outcomes should be measured.

AIM

To select outcome measurement instruments (OMIs) for a COS targeting appropriate polypharmacy in older patients in primary care.

METHOD

Following the Consensus-based Standards for the selection of health Measurement Instruments (COSMIN) guideline, OMIs were identified from a Cochrane review focusing on appropriate polypharmacy. The quality of OMIs was assessed using a published checklist. Subsequently, two rounds of Delphi questionnaires were conducted via the SoGoSurvey platform, engaging stakeholders (researchers, clinicians and journal editors specialising in geriatric primary care) to achieve consensus on OMIs using a scale encompassing "agree", "disagree", or "unsure". Consensus was achieved if 70% or more participants chose "agree" and 15% or fewer chose "disagree."

RESULTS

The quality of 20 OMIs identified from the Cochrane review was evaluated. Seven OMIs were selected based on meeting the COSMIN guideline's minimum requirements. Out of 188 potential participants, 57 (30.3%) consented to participate. Rounds 1 and 2 of Delphi exercises were completed by 50 respondents, achieving agreement on three OMIs: 'number of serious adverse drug reactions (ADRs)' (98%), 'number of deaths' (76%), and 'number of patients who fell' (70%) for measuring 'serious ADRs,' 'mortality,' and 'falls,' respectively. No agreement was reached for 'medication appropriateness,' 'medication side-effects,' 'quality of life,' and 'medication regimen complexity.'

CONCLUSION

OMIs were selected for a limited number of outcomes in the polypharmacy COS. Future research should identify suitable OMIs for the remaining four outcomes.

摘要

背景

尽管在初级保健中制定了一个多药治疗核心结局集(COS),但仍不清楚应该如何衡量这些结局。

目的

为初级保健中老年患者的适当多药治疗选择一个 COS 的结局测量工具(OMI)。

方法

根据共识基础的健康测量仪器选择标准(COSMIN)指南,从一项专门针对适当多药治疗的 Cochrane 综述中确定了 OMI。使用已发表的清单评估 OMI 的质量。随后,通过 SoGoSurvey 平台进行了两轮 Delphi 问卷调查,让利益攸关方(研究人员、临床医生和专门从事老年初级保健的期刊编辑)参与,使用涵盖“同意”、“不同意”或“不确定”的量表就 OMI 达成共识。如果 70%或更多的参与者选择“同意”,而 15%或更少的参与者选择“不同意”,则达成共识。

结果

对从 Cochrane 综述中确定的 20 个 OMI 的质量进行了评估。根据符合 COSMIN 指南最低要求,选择了 7 个 OMI。在 188 名潜在参与者中,有 57 名(30.3%)同意参与。在第一轮和第二轮 Delphi 练习中,有 50 名受访者完成了练习,就三个 OMI 达成了一致:“严重药物不良反应(ADR)的数量”(98%)、“死亡人数”(76%)和“跌倒人数”(70%),分别用于衡量“严重 ADR”、“死亡率”和“跌倒”。对于“药物适宜性”、“药物副作用”、“生活质量”和“药物治疗方案的复杂性”,没有达成一致意见。

结论

为多药治疗 COS 中的一些结局选择了 OMI。未来的研究应该为其余四个结局确定合适的 OMI。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验